Combination therapy targeting cancer metabolism

Area of Science:

• Oncology
• Cellular Metabolism
• Biochemistry

Background:

• Cancer cells exhibit significant metabolic reprogramming to support rapid proliferation.
• Hypoxia-Inducible Factors (HIF-1α and HIF-2α) play a crucial role in mediating these metabolic adaptations.
• Cancer cells enhance glycolysis and mitochondrial respiration for energy and macromolecule synthesis, while managing reactive oxygen species (ROS).

Purpose of the Study:

• To elucidate the metabolic adaptations in cancer cells.
• To investigate the role of HIF-1α and HIF-2α in cancer metabolism.
• To identify potential synergistic therapeutic targets based on metabolic vulnerabilities.

Main Methods:

• Analysis of metabolic pathways in cancer cells.
• Investigation of HIF-1α and HIF-2α induction during cellular transformation.
• Assessment of ROS accumulation and antioxidant enzyme activity.

Main Results:

• Cancer cells upregulate both glycolysis and mitochondrial respiration.
• HIF-1α and HIF-2α induction optimizes energy production and macromolecule synthesis.
• Antioxidant enzymes are induced to counteract ROS, mitigating oxidative damage.

Conclusions:

• Targeted inhibition of HIF pathways presents a viable anti-cancer strategy.
• Disrupting cellular antioxidant defenses can synergize with HIF inhibition.
• Combination therapy targeting HIF and oxidative stress mitigation offers a promising approach for cancer treatment.